Hexabax

Research and Data Analytics

We specialize in the systematic collection, analysis, and interpretation of data, leveraging state-of-the-art tools and methodologies to extract valuable insights for our client organizations. Our data-driven approach involves gathering of relevant data from various sources, followed by analysis to uncover patterns, trends, and correlations. Through in-depth interpretation, we transform raw data into actionable insights that empower our clients to make informed decisions and strategic choices. 

Survey & Data Collection

Survey and data collection involve systematically gathering information through questionnaires, interviews, or observations to obtain insights, opinions, or facts for analysis and decision-making.
READ MORE

Third Party Validation

Hexabax uses an effective process of obtaining independent verification or confirmation of a product, service, or claim from an impartial entity, enhancing credibility and trustworthiness.
READ MORE

Impact Evaluation

We use a systematic approach to assess the long-term effects and outcomes of an intervention, program, or policy, aiming to determine its effectiveness and influence on desired goals.
READ MORE

Research & Feasibility Studies

We conduct comprehensive research and feasibility assessments to evaluate the practicality, relevance, and sustainability of proposed projects or interventions, identifying potential risks, opportunities, and resource requirements to ensure evidence-based planning and effective implementation.
READ MORE
Research and Data Analytics

Relevant Projects

Punjab Health Survey Round II (2018)

Designed tools, trained enumerators, and analyzed provincial health data to inform planning and decision-making.

Tagging of Bio-Medical Equipment (2018)

Surveyed and tagged biomedical equipment across hospitals for PESSI to enable asset planning and traceability.

3rd Party Evaluation of Waterless Dyeing Facility (2020)

Evaluated feasibility and performance of waterless dyeing technology implemented by TUSDEC.